MIAMI—Talent Testing Service announced the release of its July 2024 update on the latest positivity rates of Sexually Transmitted Diseases (STDs).
Chlamydia Urine - Positivity Index
Overall, the three Chlamydia Urine rates show a similar behavior over time including the steady downward trend from the November 2022 peak.
In July 2024, all the rates dropped from the June level of 1.4%, with the Total rate down to 0.8%, the Female rate to 1.0%, and the Male to 0.6%. Seeing that historic levels have been around 2.0%, the current rates being below 2.0% can be considered to be within expectations.
GC (Gonorrhea) Urine - Positivity Index
In July 2024 the three Gonorrhea Urine rates are lower, the Female rate is down to 0.5% from 1.2%, the Total rate at 0.3% from 0.7%, and the Male rate at 0.2% from 0.3%. In this month the three rates remain within the trend.
Trichomonas Vaginalis Urine- Positivity Index
In July 2024 the Female rate turned down to 0.6% from 0.7%, the Total rate also decreased to 0.3% from 0.4%, while the Male rate is just up to 0.1% from 0.0%. The current rate levels are still within the general range of 0.0% to 1.5%.
Mycoplasma Genitalium Urine – Positivity Index
In July 2024 the Total rate went up to 4.9% from 4.1%, the Male rate also increased to 5.0% from 2.6%, and the Female rate dropped to 4.9% from 5.4%.
Chlamydia & GC (Gonorrhea) Throat and Rectal Swabs – Positivity Index
Based on market activity the positivity rates for the four tests below have December 2022 as a relevant, starting point where all levels display their peak and then start overall downward trends. In July 2024, the Total Chlamydia Rectal rate showed a decrease to 1.1% from 1.3%, the Female rate also dropped to 1.3% from 1.8%, and the Male rate is up to 0.9% from 0.7%. The Chlamydia Throat rates continue to be aligned with their general trend with levels at or below 1.0%, with the Male rate at 0.3% from 0.2%, the Total rate at 0.5% from 0.3%, and the Female rate also up at 0.7% from 0.4%.
Although within an overall smaller range of 0.0% to 3.5% when compared to the other swab rates, the Gonorrhea Rectal lines volatility, visible since April 2023, continues with the Total rate turning up to 0.9% from 0.7%, the Female rate going down to 0.8% from 1.0%, and the Male rate increasing to 1.1% from 0.3%. The three Gonorrhea Throat rates have made a sharp upward turn with the Female rate going up to 2.0% from 0.8%, the Male rate up to 1.9% from 1.0%, and the Total rate up to to 2.0% from 0.9%.
In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests.
